Navigation Links
Phosphagenics Initiates its Phase 2 Clinical Trial in Type 1 Diabetes
Date:3/19/2008

MELBOURNE, Australia, March 19 /PRNewswire-FirstCall/ -- Phosphagenics Limited (ASX: POH, AIM: PSG, OTCQX: PPGNY) today announced that it has received ethics approval to commence treating patients with Type 1 diabetes in a Phase 2 clinical trial using its patented transdermal insulin delivery system, TPM/Insulin. The lead clinical investigators of the trial will be Dr. Michael D' Emden, Department of Endocrinology, Royal Brisbane and Women's Hospital, and William Hsu, who is an Assistant Investigator in the Section on Clinical Research at the Joslin Diabetes Centre and an Assistant Professor of Medicine at Harvard Medical School, Boston, MA.

Ethics approval was granted on the basis of data generated from previous trials and the first arm of the Phase 2 trial, which involves the treatment of patients with Type 2 diabetes. Phosphagenics had to demonstrate safety and the effective delivery of insulin into the bloodstream of patients with Type 2 diabetes prior to receiving ethics approval to commence a trial for patients with Type 1 diabetes.

The Phase 2 trial in Type 1 patients is due to commence next month and will be conducted at QPharm in Queensland, Australia. QPharm is a well- established clinical facility and uniquely placed to conduct this type of diabetes trial. The trial is a randomized, single-blinded trial which aims to assess the efficacy of TPM/Insulin. The results of this trial will be used to assist in obtaining an IND from the FDA. This will enable Phosphagenics to commence the next phase of its clinical development program for TPM/Insulin at the Joslin Diabetes Centre. It is anticipated that the U.S. portion of the study will start this year.

"We have gathered the appropriate positive data to progress our Phase 2 study to the treatment of patients with Type 1 diabetes, which is the ideal patient population to prove the efficacy of our TPM/Insulin," said Dr. Esra Ogru, Executive Vice President of Research and Development at P
'/>"/>

SOURCE Phosphagenics Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
2. Phosphagenics to Commence Phase 2 TPM/Insulin Clinical Trial
3. Phosphagenics to Conduct a Phase 1 Transdermal Oxycodone Clinical Trial
4. Nestle Nutrition and Phosphagenics to Commence Phospha E(R) Phase 2 Clinical Trial
5. Update on Progression of Phosphagenics and Nestle Nutritions Phospha E(R) Trial
6. Phosphagenics Initiates U.S. Clinical Trials for Its Topical Retinoic Acid
7. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
8. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
9. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
10. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
11. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... ALBANY, New York , August 20, 2014 /PRNewswire/ ... published a new market report titled "Monochloroacetic Acid (MCA) ... Other Applications - Global Industry Analysis, Size, Share, Growth, ... acid market was valued at USD 817.1 million in ... by 2020, growing at a CAGR of 3.6% during ...
(Date:8/20/2014)... , Aug. 20, 2014 ... of the "Global Advanced Wound Care and ... - Size, Share, Global Trends, Company Profiles, Demand, ... 2013 - 2020" report to their offering. ... advanced wound care and closure market (types, applications, ...
(Date:8/20/2014)... 2014  Decision Resources Group finds that ... device market will expand through 2023 as ... fibrillation (AF). The increasing acceptance of ablation ... will spur adoption of premium-priced products designed ... loop diagnostic catheters, cryoablation catheters and contact ...
Breaking Medicine Technology:Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 3Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 4Global Advanced Wound Care and Closure Market (Types, Applications, End User and Geography) - Forecast to 2020 2Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 2Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 3
... Services, Inc. (NYSE: WST ) announced today that it ... opens on Tuesday, November 3, 2009 and will follow with ... at 9:00 a.m. Eastern Time. To participate on the call ... A live broadcast of the conference call will be available ...
... Inc. (NYSE: HSP ), a leading global specialty ... the third quarter ended Sept. 30, 2009. Net sales ... earnings per share were $0.90. (Adjusted* measures exclude certain ... and the attached schedules.) , "Hospira delivered strong results ...
Cached Medicine Technology:West to Host 2009 Third Quarter Conference Call 2Hospira Reports Third-Quarter 2009 Results 2Hospira Reports Third-Quarter 2009 Results 3Hospira Reports Third-Quarter 2009 Results 4Hospira Reports Third-Quarter 2009 Results 5Hospira Reports Third-Quarter 2009 Results 6Hospira Reports Third-Quarter 2009 Results 7Hospira Reports Third-Quarter 2009 Results 8Hospira Reports Third-Quarter 2009 Results 9Hospira Reports Third-Quarter 2009 Results 10Hospira Reports Third-Quarter 2009 Results 11Hospira Reports Third-Quarter 2009 Results 12Hospira Reports Third-Quarter 2009 Results 13Hospira Reports Third-Quarter 2009 Results 14Hospira Reports Third-Quarter 2009 Results 15Hospira Reports Third-Quarter 2009 Results 16Hospira Reports Third-Quarter 2009 Results 17Hospira Reports Third-Quarter 2009 Results 18Hospira Reports Third-Quarter 2009 Results 19Hospira Reports Third-Quarter 2009 Results 20Hospira Reports Third-Quarter 2009 Results 21Hospira Reports Third-Quarter 2009 Results 22Hospira Reports Third-Quarter 2009 Results 23Hospira Reports Third-Quarter 2009 Results 24Hospira Reports Third-Quarter 2009 Results 25Hospira Reports Third-Quarter 2009 Results 26Hospira Reports Third-Quarter 2009 Results 27Hospira Reports Third-Quarter 2009 Results 28
(Date:8/20/2014)... NY (PRWEB) August 20, 2014 Ticket Down ... Championship tickets in NYC. In just a week, the ... Jean King Tennis Center. The event was originally founded in 1881 ... event, Rafael Nadal was forced to withdrawal from the event because ... 2014 women’s tournament and will return to New York City with ...
(Date:8/20/2014)... Dennis Thompson HealthDay Reporter ... rates fell dramatically during the past two decades, plummeting 57 ... report shows. An estimated 4 million fewer births occurred ... researchers from the U.S. Centers for Disease Control and Prevention. ... from the report," said Bill Albert, chief program officer of ...
(Date:8/20/2014)... patient and tumor characteristics for melanomas with higher ... in an effort to increase earlier detection of ... , Author: Sarah Shen, M.B.B.S., B.Med.Sci., of Alfred ... The tumor characteristic known as mitotic rate ... prognosis and survival in melanoma patients. However, the ...
(Date:8/20/2014)... of Adelaide researchers have discovered that the immune system ... is a major reason why sufferers have ongoing issues with ... in the world could also help to explain why ... Irritable bowel syndrome (IBS) affects up to 10% of the ... of them involve unexplained gut pain, which often has the ...
(Date:8/20/2014)... is now, Free content, The time to deploy ... being published early online today in Annals ... School of Public Health write that the relentless epidemiologic ... represent a public health crisis that shows no signs ... been developed in the last decade, yet the sporadic ...
Breaking Medicine News(10 mins):Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 2Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 4Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 5Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 2Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 3Health News:Patient, tumor characteristics for high-mitotic rate melanoma 2Health News:Pain treatments less effective for those with irritable bowel 2Health News:News from Annals of Internal Medicine 2
... Schweitzer (Chair of the Democratic Governors Association) and Maryland ... applauded President Obama,s reported selection of former DGA Chair ... Services. "Our health care system is broken, and Governor ... effort to fix it," Governor Schweitzer said. "In reforming ...
... rare, orphan and neglected diseases, launches iWish, which allows people to ... diseases through and image. In addition, people are invited to explain ... solutions for a rare disease or for the community in general. ... ...
... research presented at the 2009 American Orthopaedic Society of ... elbow ulnar collateral ligament (UCL) reconstruction prior to selection ... increase the risk of future injury or affect the ... no statistical difference between athletes who had undergone UCL ...
... Communication Service introduces vSling for capturing and distributing ... Smile Reminder will highlight their newest practice-to-patient ... Society Midwinter Meeting. Attracting thousands of dental practitioners ... platform for Smile Reminder to show its revenue ...
... experts urge better awareness of how machines work , , ... clearing the sidewalk quicker and easier, but those who ... with hand injuries and accidental amputations, say medical experts. ... not the type of injuries that can be reconstructed," ...
... 27 LCA-Vision Inc. (Nasdaq: LCAV ) ... independent research and proxy advisory firm, today recommended that ... of Directors and reject all of the proposals, including ... replacement Directors, in the Joffe Group,s consent solicitation. ...
Cached Medicine News:Health News:CheckOrphan Launches iWish to Commemorate Rare Disease Day 2Health News:CheckOrphan Launches iWish to Commemorate Rare Disease Day 3Health News:Elbow ligament reconstruction appears not to effect future professional advancement in baseball 2Health News:Smile Reminder Showcases Viral Marketing Tool at Chicago Dental Society's Midwinter Meeting 2Health News:Smile Reminder Showcases Viral Marketing Tool at Chicago Dental Society's Midwinter Meeting 3Health News:Snowblower Hand Injuries Often Extensive, Study Finds 2Health News:Glass Lewis Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Three Proposals by Dissident Joffe Group 2Health News:Glass Lewis Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Three Proposals by Dissident Joffe Group 3Health News:Glass Lewis Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Three Proposals by Dissident Joffe Group 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: